BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).
BioLine Rx has a consensus price target of $9.00.
The stock price for BioLine Rx (NASDAQ: BLRX) is $0.641488 last updated September 25, 2024 at 10:46 AM EDT.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q3 earnings are confirmed for Monday, November 18, 2024.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.